Imperial College London
Alternate

Professor Toby Maher

Faculty of Medicine, National Heart & Lung Institute

Professor of Interstitial Lung Disease
 
 
 
//

Contact

 

+44 (0)20 7594 2151t.maher

 
 
//

Assistant

 

Ms Georgina Moss +44 (0)20 7594 2151

 
//

Location

 

364Sir Alexander Fleming BuildingSouth Kensington Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Whitty:2020:10.1183/13993003.01157-2019,
author = {Whitty, JA and Rankin, J and Visca, D and Tsipouri, V and Mori, L and Spencer, L and Adamali, H and Maher, TM and Hopkinson, NS and Birring, SS and Farquhar, M and Wells, AU and Sestini, P and Renzoni, EA},
doi = {10.1183/13993003.01157-2019},
journal = {European Respiratory Journal},
title = {Cost-effectiveness of Ambulatory Oxygen in improving quality of life in fibrotic lung disease: Preliminary evidence from the AmbOx Trial.},
url = {http://dx.doi.org/10.1183/13993003.01157-2019},
volume = {55},
year = {2020}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Ambulatory oxygen may be cost-effective in improving quality of life in fibrotic lung disease. To be more conclusive, we need to understand societal willingness to pay for quality of life improvements and whether improvements are sustained. http://bit.ly/2pAiBJi
AU  - Whitty,JA
AU  - Rankin,J
AU  - Visca,D
AU  - Tsipouri,V
AU  - Mori,L
AU  - Spencer,L
AU  - Adamali,H
AU  - Maher,TM
AU  - Hopkinson,NS
AU  - Birring,SS
AU  - Farquhar,M
AU  - Wells,AU
AU  - Sestini,P
AU  - Renzoni,EA
DO  - 10.1183/13993003.01157-2019
PY  - 2020///
SN  - 0903-1936
TI  - Cost-effectiveness of Ambulatory Oxygen in improving quality of life in fibrotic lung disease: Preliminary evidence from the AmbOx Trial.
T2  - European Respiratory Journal
UR  - http://dx.doi.org/10.1183/13993003.01157-2019
UR  - https://www.ncbi.nlm.nih.gov/pubmed/31699838
UR  - https://erj.ersjournals.com/content/early/2019/10/17/13993003.01157-2019
UR  - http://hdl.handle.net/10044/1/74967
VL  - 55
ER  -
Download